Top Markets
Coin of the day
Chordia Therapeutics Inc. Chordia Therapeutics Inc.

Chordia Therapeutics Inc.

190A
Peringkat dalam Saham #26480
Chordia Therapeutics Inc., a biotech company, engages in research and... Chordia Therapeutics Inc., a biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan. It develops CLK CTX-712, a CLK inhibitor, which is Phase 1 clinical trial for the treatment of relapsed or refractory malignant cancers.; CTX-177, a small-molecule inhibitor of MALT1; CDK12 inhibitor CTX-439; and GCN2 inhibitor CRD-1968099. Chordia Therapeutics Inc. was incorporated in 2017 and is based in Fujisawa, Japan.
Harga Saham
$0.53499835
Kapitalisasi Pasar
$40.24M
Perubahan (1 hari)
2.50%
Perubahan (1 tahun)
-58.07%
Negara
JP
Perdagangan Chordia Therapeutics Inc. (190A)

Kategori

Riwayat harga saham Chordia Therapeutics Inc. (190A)
Harga penutupan tertinggi: $0.53 pada 2026-08-01

Harga penutupan terendah: $1.06 pada 2024-06-01
Riwayat harga saham Chordia Therapeutics Inc. dari 2024 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 10.93%
2025 -61.05%
2024 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$546.54 38.59%
US
$1.04K 56.71%
NL
$120.74 -14.98%
AU
$138.98 416.85%
US
$761.87 7.04%
CH